Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: Association with human esophageal cancer

Oncogene

Volumn 19, Issue 3, 2000, Pages 323-328

  Bahl, Rimple ^a   Arora, Sonia ^a   Nath, Neera ^a   Mathur, Meera ^a   Shukla, Nootan K ^b   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Cyclin dependent kinase inhibitor; Esophageal squamous cell carcinomas; P21(waf1 cip1); p53

Indexed keywords

ADENINE; ARGININE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; CYTOSINE; PROTEIN P21; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CODON; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0034688230     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203325     Document Type: Article

References (36)

1. Agarwal S, Mathur M, Shukla NK and Ralhan R. (1998). Oral Onco. Eur. J. Cancer, 34, 1-8.
2. Barbareschi M, Caffo O, Doglioni C, Fina P, Marchetti A, Buttitla F, Leek R, Moreedi L, Leonardi E, Bevilacqua G, Palma PD and Hattis AL. (1996). Br. J. Cancer, 74, 208 215.
3. Bukholm IK, Nesland JM, Karseen R, Jacobsen U and Borrensen-Dale AL. (1997). Int. J. Cancer, 73, 38-41.
4. Cayrol C, Knibichler M and Ducommun B. (1998). Oncogene, 16, 311-320.
5. Chen J, Jackson PK, Kirschner MW and Dutta A. (1995). Nature, 375, 386-388.
6. Doglioni C, Pelosio P, Laurino L, Macri E and Barbaresehi M. (1996). J. Pathol., 179, 248-253.
7. Elbendary AA, Cirisano FD, Evans AC, Davis PL, Iglehart JD, Marks JR and Berchuck A. (1996). Clin. Cancer Res., 2, 1571-1575.
8. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 2910-2919.
9. Facher EA, Becich MJ, Deka A and Law JC. (1997). Cancer, 79, 2424-2429.
10. Flores-Rozas H, Kelman Z, Dean FB, Pan Z, Harper JW, Elledge SJ, O'Donnel M and Hurtwitz J. (1994). Proc. Natl. Acad. Sci. USA, 91, 8655-8659.
11. Gaur D, Arora S, Mathur M, Nath N, Chattopadhay TK and Ralhan R. (1997). Clin. Cancer Res., 3, 2129-2136.
12. Goubin F and Ducommun B. (1995). Oncogene, 10, 2281 2287.
13. Gujuluva CN, Baek JH, Shin KH, Cherrick HM and Park NH. (1994). Oncogene, 9, 1819-1827.
14. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M and Kuriyan J. (1996). Cell, 87, 297-306.
15. Heinzel PA, Balaram P and Bernard MU. (1996). Int. J. Cancer, 68, 420-423.
16. Huppi K, Siwarski D, Dosik J, Michieli R, Chedid M, Reed K, Mock B, Givol D and Mushinsky JF. (1994). Oncogene, 9, 3017-3020.
17. Koopmann J, Maintz D, Schild S, Schramm J, Loius DN, Wiestler OD and Deimling A. (1995). Br. J. Cancer, 72, 1230-1233.
18. Landis SH, Taylor M, Bolden S and Wingo PA. (1999). Cancer J. Clin., 49, 8-32.
19. Li R, Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 371, 534-537.
20. Luo Y, Hurwitz and Massague J. (1995). Nature, 375, 159 161.
21. Marchetti A, Buttitta F, Pellegrini S, Lori A, Bertacca G and Bevi-Lacqua G. (1996a). Int. J. Oncol., 6, 187-189.
22. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Chella A, Angeletti CA, Datta PP and Bevilacqua G. (1996b). Oncogene, 12, 1319-1324.
23. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB and Andrulis IL. (1995). Hum. Mol. Genet., 4, 1089-1092.
24. Munoz N and Day NE. (1996). Oesophagus: In: Schottenfeld N and Fraumeni Jr JF. (eds). Cancer Epidemiology and Prevention (2 edn), Oxford University Press: Oxford. pp. 681-706.
25. Nakanishi M, Robetorye RS, Pereira Smith OM and Smith JR. (1995). J. Biol. Chem., 270, 17060-17063.
26. Notani PN. (1988). E. Epidemiol. Comm. Hlth., 187.
27. Ralhan R, Arora S, Chattopadhyay TK, Shukla N and Mathur M. (1999). Int. J. Cancer (In Press).
28. th edn., Wiley-Liss: New York.
29. Sambrook J, Fritsh EF and Maniatis T (Eds.) (1989). In: Molecular Cloning: Cold Spring Harbor Laboratories, Cold Spring Harbor: New York.
30. Shimada Y, Imamura M, Wantabe G, Uchida S, Harada H, Makino T and Kano M. (1999). Br. J. Cancer, 80, 1281-1288.
31. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B and Koeffler HP. (1994). Blood, 84, 3781-3784.
32. Siddiqi MA, Tricker AR, Fazili Z and Preussman R. (1991). In: O'Neill IK, Chen J and Bartsh H (eds.) Dietary sources of N-nitrosamines in high risk area for esophagel cancer: Kashmir, India. Relevance to human cancer of the N-nitroso compounds. IARC Lyon, France, pp. 210-213.
33. Vidal MJ, Loganzo F, de Olivera, Hayward NK and Albino AP. (1995). Melonoma Res., 5, 243-250.
34. Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 369, 574-578.
35. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature (Lond), 366, 707-710.
36. Yu MC, Garabrant DM, Peters JM and Mack TM. (1988). Cancer Res., 48, 345-348.